CYMBATEX 30MG 30 CAP

each delayed release capsule contains :active ingredients : duloxetine hydrochloride 33.65 mg . Equivalent to duloxetine 30 mg .

166.00 EGP

Purchase this product now and earn 166 Points!

CYMBATEX 30MG 30 CAP; duloxetine, antidepressants .

ACTIVE-INGREDIENT OF CYMBATEX 30MG 30 CAP

each delayed release capsule contains :active ingredients : duloxetine hydrochloride 33.65 mg . Equivalent to duloxetine 30 mg .

INDICATION OF CYMBATEX 30MG 30 CAP

treatment of major depressive disorder . Treatment of diabetic peripheral neuropathic pain . Treatment of generalised anxiety disorder . Cymbatex is indicated in adults .

DOSAGE OF CYMBATEX 30MG 30 CAP

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

major depressive disorder : the starting and recommended maintenace dose is 60 mg once daily with or without food . Dosages above 60 mg once daily , up to a maximum dose of 120 mg per day have been evaluated from a safety perspective in clinical trials . however , there is no clinical evidence suggesting that patients not respondding to the initial recommended dose may benefit from dose up-titrations . therapeutic response is usually seen after 2-4 weeks of treatment . after consolidation of the antidepressive response , it is recommended to continue treatment for several months , in order to avoid relapse . in patients responding to duloxetine , and with a history of repeated episodes of major depression , further long-term treatment at a dose of 60 to 120 mg /day could be considered . generalised anxiety disorder ; the recommended starting dose in patients with generalised anxiety disorder is 30 mg once daily with or without food . in patients with insufficient response ,

OVER-DOSAGE OF CYMBATEX 30MG 30 CAP

CONTRA-INDICATION OF CYMBATEX 30MG 30 CAP

hypersensitivity to the active substance or to any of the excipients concomitant use of duloxetine with non selective , irreversible monoamine oxidase inhibitors ( MAOIs ) is contraindicated . Liver disease resulting in hepatic impairment . Duloxetine should not be used in combination with fluvoxamine , ciprofloxacin , or enoxacin ( i.e. potent CYP1A2 inhibitors ) , since the combination results in elevated plasma concentrations of duloxetine . sever renal impairment ( creatinine clearance STORAGE OF CYMBATEX 30MG 30 CAP

store in a dry place , at a temperature not exceeding 30 C . KEEP OUT OF REACH OF CHILDREN
PACK OF CYMBATEX 30MG 30 CAP
carton box containing 1,2,3 (AL/AL) blisters each of 10 hard gelatin capsules with insert leaflet .
CYMBATEX 30MG 30 CAP MANUFACTURED BY
EVA PHARMA

https://www.evapharma.com/portfolio/cymbatex-30-mg/

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

Reviews

There are no reviews yet.

Show reviews in all languages (1)

Be the first to review “CYMBATEX 30MG 30 CAP”

Your email address will not be published.

Shopping Cart
Don`t copy text!
Scroll to Top